Pay in 4 interest-free payments of $6.68 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Which Treatment Is Right for You
In a phase 2, randomized, double-blind, placebo-controlled trial (NCT04881760) involving adults with obesity without type 2 diabetes, retatrutide (1 mg12 mg weekly) produced dose-dependent weight loss of up to 24.2% from baseline at 48 weeks, compared with 2.1% with placebo
Some Aetna plans exclude weight loss medications from coverage, while others cover the medication under certain conditions
Because it is a branded product, it has undergone extensive clinical trials specifically for the purpose of weight loss in adults with a high Body Mass Index (BMI) or weight-related medical conditions
Studies aimed at identifying potential receptors/binding sites for enterostatin demonstrated that membranes from neural tissues possessed both high-affinity and a low-affinity binding sites
Its multifaceted roles extend to potential involvement in synapse maturation and the Ca(2+)-dependent exocytosis essential for sensory perception of smell in the olfactory bulb
-1.jpg&w=3840&q=75)
US$ 21.38
US$ 23.16
US$ 20.69
